EXCLUSIVE: Cibus Expands Intellectual Property Coverage For 10 Plant Gene Editing And Trait Families
EXCLUSIVE: Cibus Expands Intellectual Property Coverage For 10 Plant Gene Editing And Trait Families
On Wednesday, Cibus Inc (NASDAQ:CBUS) announced that it has expanded its intellectual property coverage for ten gene editing and trait families.
週三，Cibus股份有限公司（NASDAQ:CBUS）宣佈擴展了其十個基因編輯和特徵家族的知識產權覆蓋範圍。
Over the last six months, intellectual property expansion has covered several areas, including gene editing, productivity traits, and quality traits, like high-fiber wheat.
在過去的六個月中，知識產權擴展了包括基因編輯、生產力特徵和質量特徵（如高纖維小麥）在內的多個領域。
This strengthens the company's patent coverage in geographies including, but not limited to, Europe, Asia, Latin America, Canada, and the U.S.
這加強了該公司在歐洲、亞洲、拉丁美洲、加拿大和美國等地區掌握的專利覆蓋範圍。
Cibus is focused on developing complex gene-edited traits in plants, such as Pod Shatter Reduction in Canola and Herbicide Tolerance in Rice.
Cibus致力於開發一些植物中的複雜基因編輯性狀，如油菜籽的莖軸裂解減小和水稻的除草劑耐受性等。
The company's plant trait intellectual property is developed using its Rapid Trait Development System (RTDS), which includes Gene Repair Oligonucleotides (GRON) and Transcription activator-like effector nuclease (TALEN) technology.
該公司的植物性狀知識產權是使用其快速性狀開發系統（RTDS）開發的，其中包括基因修復寡核苷酸（GRON）和轉錄激活因子樣效應核酸（TALEN）技術。
The patents announced solidify Cibus' intellectual property depth, driving product development and highlighting the strengths of its diversified portfolio of traits.
這些專利的宣佈鞏固了Cibus的知識產權深度，推動產品開發，凸顯了其多樣化特徵組合的優勢。
Between Cibus and legacy Calyxt, Cibus now has rights to over 1,000 patents and patents applied for, including core original gene editing patents in agriculture.
在Cibus和其前身Calyxt之間，Cibus現在擁有超過一千項專利和專利申請，包括農業中的原始基因編輯專利。
"We are pleased with the recognition of the patent offices in many countries, who through their decisions have validated our know-how and ability to develop gene-edited traits," commented Greg Gocal, Co-Founder, Executive Vice President and Chief Scientific Officer at Cibus.
“我們對許多國家的專利局對我們的承認感到高興，通過他們的決定，他們證實了我們發展基因編輯特徵的能力和專業知識，” Cibus創始人、執行副總裁兼首席科學官Greg Gocal評論道。
Noel Sauer, Senior Vice President of Research at Cibus, added, "Cibus' technology team actively supports the company's commercial advancement efforts through protection of our trait and gene editing intellectual property. Importantly, protected traits can help accelerate our seed company customers' timelines to farmer's fields across global markets."
Cibus研究高級副總裁Noel Sauer補充說：“Cibus的技術團隊通過保護我們的性狀和基因編輯知識產權，積極支持公司的商業推進工作。重要的是，受保護的特徵可以幫助加快我們面向全球市場的種子公司客戶的時間表。”
Price Action: CBUS shares closed at $9.00 on Tuesday.
CBUS股票週二收盤價爲9.00美元。
譯文內容由第三人軟體翻譯。